Free Webinar Replay: Pills and Beyond: A Guide to the Formulations and Delivery Options of ADHD Medication
In this hour long webinar on demand, learn about the different ADHD medication formulations and delivery systems available with Laurie Dupar, PMHNP, RN, PCC.
In the past, the treatment of attention deficit disorder (ADHD or ADD) was largely limited to short-acting pills. However, this one-size-fits-all treatment method posed challenges for some patients — difficulty swallowing, problems in adjusting the dose, short administration windows, inconsistency of effects, and inadequate duration to name a few. Thankfully, a more diverse range of ADHD treatment formulations and delivery systems is available today. But what differentiates these options? And how do you know which one(s) may be right for you or a loved one?
Join Laurie Dupar — trained Psychiatric Mental Health Nurse Practitioner, veteran ADHD life coach, and director at the International ADHD Coach Training Center — as she reviews, in easy-to-understand language, the various medication formulations and delivery options available today for ADHD treatment.
In this webinar you will learn:
- The different types of ADHD medications available today — and how they are formulated and administered
- Which FDA-approved ADHD treatment options you can swallow, sprinkle, or stick to your skin
- Which new, FDA-approved treatment option isn’t a medication
- Which ADHD medications work quickly, which last longer, and which you can take at night
- How ADHD medications work and which one may be right for you
Webinar replays include:
- Slides accompanying the webinar
- Related resources from ADDitude
- Free newsletter updates about ADHD
- An opportunity to receive a certificate of attendance
This ADHD Experts webinar was first broadcast live on August 1, 2019.
Clarification on the delivery system of Jornay PM, a new methylphenidate medication for patients ages 6 years and older:
Jornay PM is a stimulant medication that is taken in the evening but has a unique delayed-release technology that keeps it from working for about 12 hours; the patient wakes up the following morning with a therapeutic blood level of methylphenidate. In its highlights of prescribing information, the FDA cites clinical trials that prove the efficacy of Jornay PM, when taken between 6:30 pm and 9:30 pm the night before, at controlling ADHD symptoms in the morning. Jornay PM’s extended-release layer then controls ADHD symptoms throughout the day. Jornay PM’s proprietary drug delivery platform, called Delexis, is explained on https://www.ironshorepharma.com/delexis.html, which details this micro-bead technology, how it works, and how it achieves delayed release through interaction with the patient’s GI tract.
For more information on Jornay PM, please visit www.jornaypm.com.
Meet the Expert Speaker:
Laurie Dupar, PMHNP, RN, PCC, is a senior certified ADHD Coach, trained psychiatric nurse, and founder of the International ADHD Coach Training Center. She specializes in working with clients who have been diagnosed with ADHD and who want to understand how their brain works, minimize their challenges, and get things done. For more information about Laurie’s programs, visit coachingforadhd.com.